{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:05:35Z","timestamp":1784070335618,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2022R1C1C1003491"],"award-info":[{"award-number":["2022R1C1C1003491"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tice.2026.103628","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:19:15Z","timestamp":1779232755000},"page":"103628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reynosin targets the PRDX6-AKT-WEE1 axis to suppress osteosarcoma and preserve the bone microenvironment"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6504-1610","authenticated-orcid":false,"given":"Hyung-Mun","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonyeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ran","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103628_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.lfs.2016.01.024","article-title":"Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation","volume":"147","author":"An","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.tice.2026.103628_bib2","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/cncr.11456","article-title":"Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor","volume":"97","author":"Bacci","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.tice.2026.103628_bib3","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.ejca.2005.08.026","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy","volume":"41","author":"Bacci","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tice.2026.103628_bib4","doi-asserted-by":"crossref","DOI":"10.4322\/acr.2023.466","article-title":"Chondroblastic osteosarcoma","volume":"13","author":"Bhardwaj","year":"2023","journal-title":"Autops Case Rep."},{"key":"10.1016\/j.tice.2026.103628_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.828684","article-title":"Targeting the DNA damage response for cancer therapy by inhibiting the Kinase Wee1","volume":"12","author":"Bukhari","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.tice.2026.103628_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.872480","article-title":"Antimicrobial effects and active compounds of the root of Aucklandia Lappa Decne (Radix Aucklandiae)","volume":"10","author":"Cai","year":"2022","journal-title":"Front Chem."},{"key":"10.1016\/j.tice.2026.103628_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.freeradbiomed.2009.05.024","article-title":"ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells","volume":"47","author":"Cao","year":"2009","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.tice.2026.103628_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71005","article-title":"PRDX6 drives breast cancer progression through mitochondrial biosynthesis and oxidative phosphorylation","volume":"14","author":"Dai","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.tice.2026.103628_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14740\/wjon1424","article-title":"Bimodal age distribution in cancer incidence","volume":"13","author":"Desai","year":"2022","journal-title":"World J. Oncol."},{"key":"10.1016\/j.tice.2026.103628_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.foodchem.2004.10.029","article-title":"Isolation and identification of cytotoxic compounds from Bay leaf","volume":"93","author":"Fang","year":"2005","journal-title":"Food Chem."},{"key":"10.1016\/j.tice.2026.103628_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/ars.2010.3412","article-title":"Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities","volume":"15","author":"Fisher","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.tice.2026.103628_bib12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2147\/CMAR.S431213","article-title":"Osteoclasts in osteosarcoma: mechanisms, interactions, and therapeutic prospects","volume":"15","author":"Gao","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tice.2026.103628_bib13","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-17-0520","article-title":"Molecular pathways: targeting the protein kinase wee1 in cancer","volume":"23","author":"Geenen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2026.103628_bib14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(00)02075-4","article-title":"The antioxidant paradox","volume":"355","author":"Halliwell","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tice.2026.103628_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073817","article-title":"Recent and ongoing research into metastatic osteosarcoma treatments","volume":"23","author":"Harris","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103628_bib16","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.7150\/jca.26041","article-title":"Overexpression of Peroxiredoxin 6 (PRDX6) promotes the aggressive phenotypes of esophageal squamous cell carcinoma","volume":"9","author":"He","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.tice.2026.103628_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1158\/1535-7163.MCT-09-0904","article-title":"Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells","volume":"9","author":"Ho","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tice.2026.103628_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17474086.2025.2492881","article-title":"PRDX6 knockdown sensitizes multiple myeloma cells to ferroptosis through inactivation of the PI3K\/AKT pathway","author":"Hu","year":"2025","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.tice.2026.103628_bib19","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1159\/000495934","article-title":"Expression of PRDX6 correlates with migration and invasiveness of colorectal cancer cells","volume":"51","author":"Huang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.tice.2026.103628_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jep.2017.06.011","article-title":"Aucklandia lappa DC. extract enhances gefitinib efficacy in gefitinib-resistance secondary epidermal growth factor receptor mutations","volume":"206","author":"Huang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tice.2026.103628_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114372","article-title":"Aucklandiae radix and Vladimiriae Radix: a systematic review in ethnopharmacology, phytochemistry and pharmacology","volume":"280","author":"Huang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tice.2026.103628_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2019.100230","article-title":"Risk and clinicopathological features of osteosarcoma metastasis to the lung: a population-based study","volume":"16","author":"Huang","year":"2019","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.tice.2026.103628_bib23","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tice.2026.103628_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091508","article-title":"Anti-cancer effect of thiacremonone through down regulation of peroxiredoxin 6","volume":"9","author":"Jo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2026.103628_bib25","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/21691401.2019.1593854","article-title":"Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells","volume":"47","author":"Kang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.tice.2026.103628_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.tice.2026.103628_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12061153","article-title":"Loss of PRDX6 aborts proliferative and migratory signaling in hepatocarcinoma cell lines","volume":"12","author":"Lagal","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.tice.2026.103628_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10059-009-0152-6","article-title":"Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt","volume":"28","author":"Lee","year":"2009","journal-title":"Mol. Cells"},{"key":"10.1016\/j.tice.2026.103628_bib29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/CMAR.S284195","article-title":"PRDX6 overexpression promotes proliferation, invasion, and migration of A549 cells in vitro and in vivo","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tice.2026.103628_bib30","first-page":"167","article-title":"Sesquiterpene lactones of Aucklandia lappa: pharmacology, pharmacokinetics, toxicity, and structure-activity relationship","volume":"13","author":"Liu","year":"2021","journal-title":"Chin. Herb. Med."},{"key":"10.1016\/j.tice.2026.103628_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7150\/ijbs.49514","article-title":"Inhibition of PI3K\/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tice.2026.103628_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2026.103628_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2014.02.003","article-title":"Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells?","volume":"62","author":"Mutsaers","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.tice.2026.103628_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.coph.2007.04.007","article-title":"Are peroxiredoxins tumor suppressors?","volume":"7","author":"Neumann","year":"2007","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.tice.2026.103628_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115733","article-title":"Targeting WEE1 in tumor-associated dendritic cells potentiates antitumor immunity via the cGAS\/STING pathway","volume":"44","author":"Ng","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.tice.2026.103628_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.phrs.2009.01.017","article-title":"Natural compounds for cancer treatment and prevention","volume":"59","author":"Nobili","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tice.2026.103628_bib37","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jps.20874","article-title":"Oxidative stress and apoptosis: impact on cancer therapy","volume":"96","author":"Ozben","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tice.2026.103628_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/07357907.2010.535056","article-title":"Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells","volume":"29","author":"Pak","year":"2011","journal-title":"Cancer Invest."},{"key":"10.1016\/j.tice.2026.103628_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jep.2006.12.033","article-title":"Saussurea costus: botanical, chemical and pharmacological review of an ayurvedic medicinal plant","volume":"110","author":"Pandey","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tice.2026.103628_bib40","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11914-023-00803-9","article-title":"Advances in osteosarcoma","volume":"21","author":"Panez-Toro","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.tice.2026.103628_bib41","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1089\/ars.2018.7530","article-title":"Peroxiredoxin 6 inhibits osteogenic differentiation and bone formation through human dental pulp stem cells and induces delayed bone development","volume":"30","author":"Park","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.tice.2026.103628_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tice.2026.103628_bib43","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/molecules18021418","article-title":"Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction","volume":"18","author":"Rasul","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.tice.2026.103628_bib44","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tice.2026.103628_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102212","article-title":"Peroxiredoxin 6 protects irradiated cells from oxidative stress and shapes their senescence-associated cytokine landscape","volume":"49","author":"Salovska","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.tice.2026.103628_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/17512433.2020.1738218","article-title":"Cancer prevention and treatment using combination therapy with natural compounds","volume":"13","author":"Sauter","year":"2020","journal-title":"Expert Rev. Clin. Pharm."},{"key":"10.1016\/j.tice.2026.103628_bib47","first-page":"144","article-title":"Bone matrix production in osteosarcoma","volume":"82","author":"Schulz","year":"1998","journal-title":"Verh. Dtsch Ges. Pathol."},{"key":"10.1016\/j.tice.2026.103628_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104710","article-title":"WEE1 inhibition in cancer therapy: mechanisms, synergies, preclinical insights, and clinical trials","volume":"211","author":"Thangaretnam","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tice.2026.103628_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.tice.2026.103628_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tice.2026.103628_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52971-3","article-title":"Isodeoxyelephantopin, a Sesquiterpene lactone induces ROS generation, suppresses NF-kappaB activation, modulates LncRNA expression and exhibit activities against breast cancer","volume":"9","author":"Verma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103628_bib52","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4161\/cbt.7.12.7067","article-title":"Cancer cell killing via ROS: to increase or decrease, that is the question","volume":"7","author":"Wang","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tice.2026.103628_bib53","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41419-019-2035-x","article-title":"ROS-mediated inactivation of the PI3K\/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin","volume":"10","author":"Wen","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tice.2026.103628_bib54","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.2147\/OTT.S211125","article-title":"Differential expression and effects of peroxiredoxin-6 on drug resistance and cancer stem cell-like properties in non-small cell lung cancer","volume":"12","author":"Xu","year":"2019","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.tice.2026.103628_bib55","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fphar.2018.01041","article-title":"Inhibition of WEE1 suppresses the tumor growth in laryngeal squamous cell carcinoma","volume":"9","author":"Yuan","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.tice.2026.103628_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/biof.1878","article-title":"Suffruticosol A elevates osteoblast differentiation targeting BMP2-Smad\/1\/5\/8-RUNX2 in pre-osteoblasts","volume":"49","author":"Yun","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.tice.2026.103628_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13101162","article-title":"Effect of spicatoside a on anti-osteosarcoma MG63 cells through reactive oxygen species generation and the inhibition of the PI3K-AKT-mTOR Pathway","volume":"13","author":"Yun","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.tice.2026.103628_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073582","article-title":"Vitexicarpin induces apoptosis and inhibits metastatic properties via the AKT-PRAS40 Pathway in Human Osteosarcoma","volume":"25","author":"Yun","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103628_bib59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.freeradbiomed.2014.02.001","article-title":"PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities","volume":"69","author":"Yun","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tice.2026.103628_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13070796","article-title":"Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells","volume":"13","author":"Zhao","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.tice.2026.103628_bib61","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12967-025-06582-4","article-title":"S1PR3 inhibition impairs cell cycle checkpoint via the AKT\/WEE1 pathway in oral squamous cell carcinoma","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Transl. Med."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626003216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:15:55Z","timestamp":1784067355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626003216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"alternative-id":["S0040816626003216"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103628","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reynosin targets the PRDX6-AKT-WEE1 axis to suppress osteosarcoma and preserve the bone microenvironment","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103628"}}